Metric Finance
LearnFAQ
LearnFAQ

Learn / SGRY

NASDAQ: SGRY

Surgery Partners (SGRY) stock, explained like you're 5

Surgery Partners trades on the Nasdaq under the ticker SGRY. It is a small cap company in the hospital/nursing management industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

Ticker
SGRY
Exchange
Nasdaq
Sector
Healthcare
Industry
Hospital/Nursing Management
Size
Small cap, about 1.8 billion dollars

Is Surgery Partners a small, medium or large cap company?

No. Surgery Partners is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Surgery Partners makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SGRY stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Surgery Partners (SGRY) Faces Sales And Debt Questions, Is The Stock Still Undervalued? (Simply Wall Street)
  • Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? (Yahoo Finance)
  • A passive holder reports shared voting power over 7.02M Surgery Partners (SGRY) shares. (Stock Titan)
  • Surgery Partners stock last traded at USD 14.61 on October 16, 2026, down 1.08 percent (ad-hoc-news.de)
  • Larry Robbins Opens New Position in Surgery Partners Inc (SGRY) Shares Look 39% Undervalued on GF Value (GuruFocus)

Follow SGRY in your daily brief

Each trading day at 5 PM ET we post what happened to Surgery Partners and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SGRY

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Surgery Partners stock

What does Surgery Partners do?

Surgery Partners trades on the Nasdaq under the ticker SGRY. It is a small cap company in the hospital/nursing management industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

What is the ticker symbol for Surgery Partners?

Surgery Partners trades under the ticker SGRY on the Nasdaq.

What is Surgery Partners's market cap?

Surgery Partners is a small cap stock with a market cap of about 1.8 billion dollars.

How does Surgery Partners make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SGRY stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SGRY stock every day?

Add SGRY to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SGRY daily

A free brief on Surgery Partners and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • THC · Tenet Healthcare
  • EHC · Encompass Health
  • UHS · Universal Health Services
  • ENSG · Ensign Group

Similar stocks

  • THCTenet Healthcare
  • EHCEncompass Health
  • UHSUniversal Health Services
  • ENSGEnsign Group

Compare SGRY: SGRY vs THC, SGRY vs EHC, SGRY vs UHS

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed